癌・腫瘍プロファイリングの世界市場予測（～2021）：用途別、手法別（ゲノミクス、 プロテオミクス、メタボロミクス、エピジェネティックス）、技術別（次世代シーケンシング、qPCR、in-situハイブリダイゼーション、マイクロアレイ）...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions for the Study
2.3 Macroeconomic Factor Analysis
2.3.1 Introduction
2.3.2 Demand-Side Analysis
2.3.2.1 Healthcare Expenditure Pattern
2.3.3 Supply-Side Analysis
2.3.3.1 Number of New Product Launches

3 Executive Summary (Page No. – 27)

4 Premium Insights (Page No. – 31)
4.1 Tumor Profiling Market: Market Overview
4.2 Geographic Analysis: Tumor Profiling Market, By Technique (2016)
4.3 Global Tumor Profiling Market Size, By Technology, 2016 vs 2021
4.4 Global Tumor Profiling Market Size, By Application, 2016 vs 2021
4.5 Tumor Profiling Market: Geographic Growth Opportunities

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of New Cancer Cases
5.2.1.2 Increasing Utility of Biomarkers in Tumor Profiling
5.2.1.3 Availability of Funding for Cancer Research
5.2.2 Restraints
5.2.2.1 High Capital Investments and Low Benefit Ratio for Biomarkers
5.2.2.2 Lack of Skilled Professionals and Infrastructure
5.2.3 Opportunities
5.2.3.1 Point-Of-Care Diagnostic Tests
5.2.3.2 Increasing Demand for Personalized Medicine
5.2.4 Challenges
5.2.4.1 Unclear Regulatory and Reimbursement Scenario

6 Cancer Profiling Market, By Application (Page No. – 43)
6.1 Introduction
6.2 Personalized Medicine
6.3 Diagnostics
6.4 Biomarker Discovery
6.5 Prognostics
6.6 Research Applications

7 Cancer Profiling Market, By Technique (Page No. – 54)
7.1 Introduction
7.2 Genomics
7.3 Proteomics
7.4 Epigenetics
7.5 Metabolomics

8 Cancer Profiling Market, By Technology (Page No. – 63)
8.1 Introduction
8.2 Next-Generation Sequencing (NGS)
8.3 Quantitative Polymerase Chain Reaction (QPCR)
8.4 Immunohistochemistry (ICH)
8.5 in Situ Hybridization (ISH)
8.5.1 Fluorescence in Situ Hybridization (FISH)
8.5.2 Chromogenic in Situ Hybridization (CISH)
8.6 Microarray

9 Cancer Profiling Market, By Region (Page No. – 73)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia-Pacific (APAC)
9.4.1 China
9.4.2 Japan
9.4.3 Rest of Asia-Pacific
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 95)
10.1 Overview
10.2 Battle for Market Share: Product Launch Was the Key Growth Strategy Adopted By Market Players Between 2013 and 2016
10.3 Product Launches
10.4 Agreements, Collaborations, and Partnerships
10.5 Acquisitions
10.6 Others Strategies

11 Company Profiles (Page No. – 100)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Illumina, Inc.
11.3 Qiagen N.V.
11.4 Neogenomics Laboratories, Inc.
11.5 HTG Molecular Diagnostics, Inc.
11.6 Genomic Health Inc.
11.7 Caris Life Sciences
11.8 Helomics Corporation
11.9 Nanostring Technologies, Inc.
11.10 Oxford Gene Technology
11.11 Ribomed Biotechnologies, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 143)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports
12.8 Author Details